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for FT-IRIS collecting infrared data at 6.25 or 25μm spatial res-
olution. Absorbance bands were monitored in the 1590-1720
(collagen amide I), 1485-1590 (collagen amide II), 1304-1356
(collagen integrity) and 985-1140 cm-1 (PG sugar) regions. The
quantity and distribution of collagen and PG were assessed via
the integrated area of the amide I region and the ratio of the inte-
grated area of the PG absorbance: amide I collagen absorbance
(PG/AmI), respectively. Collagen integrity was assessed via the
ratio of 1338:AmII and collagen fibril orientation was monitored
with polarized FT-IRIS, via an index of amide I: amide II peak
areas.
Results: Typical FT-IRIS images (Fig 1A) and immunohistochem-
istry and PLM images (Fig 1B) obtained from an ACI biopsy are
shown below. The collagen (Am1) image shows the distribution
of a combination of types I and II collagen. Interestingly, in most
samples, the PG distribution (PG/Am1), although reduced com-
pared to normal cartilage, was similar to the type II collagen
distribution demonstrated by immunohistochemistry. The colla-
gen integrity parameter was higher in all repair tissue samples
than normal articular cartilage, indicative of new collagen forma-
tion. The collagen fibril orientation via FT-IRIS did not display the
typical zonation of normal tissue but the fibrils were more aligned
parallel to the surface (red) in the superficial zone through to
the mid-zone in the repair tissue. There was evidence of fibrils
perpendicular to the surface in the deep zone (blue).
Fig. 1. ACI-treated repair cartilage; 12 months post-surgery. (A) FT-IRIS, and (B)
Immunohistochemical analysis.
Conclusions: Evaluation of the distribution, amount and integrity
of the macromolecular components of cartilage repair tissue is
a critical step in assessing therapeutic and repair protocols. FT-
IRIS allows this information, both qualitative and quantitative, to
be obtained from small quantities of tissue. In this study we have
demonstrated that a typical adult hyaline cartilage phenotype was
not present in these samples, based on collagen type, integrity
and orientation, and PG content. Future studies that focus on
correlation of molecular features with clinical outcome could
enhance optimization of protocols to repair cartilage defects.
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Purpose: Bone tissue regeneration is strictly dependent on ex-
tracellular matrix (ECM) components as well as by inflammatory
and degradative factors that play an important role in the evo-
lution of this process. Hyaluronan (HA), a major component of
ECM in human bone marrow, participates in cell positioning,
proliferation, differentiation at the endosteum following transplan-
tation, cooperates with chemokines in the trafficking of progenitor
cells and regulate the espression of metalloproteinases. In this
study we analysed the interaction between human mesenchymal
stem cells (h-MSCs) and a three-dimensional (3-D) HA-based
scaffold in vitro.
Methods: The expression of CXC chemokines/receptors,
CXCL8 (IL-8)/CXCR1-2, CXCL10 (IP-10)/CXCR3, CXCL12
(SDF-1)/CXCR4 and CXCL13 (BCA-1)/CXCR5 and metallopro-
teinases/inhibitors MMP-1, MMP-3, MMP-13/TIMP-1 were eval-
uated in h-MSCs grown both on plastic or on HA-based scaffold
by real-time PCR, ELISA and immunocytochemical techniques.
Moreover, to assess the direct involvment of HA, the expression
of CD44 and CD54 (two HA receptors), was also analysed.
Results: We found both at mRNA and protein levels that HA-
based scaffold induced the expression of CXCR4, CXCL13
and MMP-3 and down-modulated the expression of CXCL12,
CXCR5, MMP-13 and TIMP-1. Moreover, we demonstrate that
HA-based scaffold induced CD54 expression but not CD44. We
found that these two HA receptors were directly involved in the
modulation of CXCL12, CXCL13 and CXCR5.
Conclusions: This study demonstrates a direct action of a 3-D
HA-based scaffold, widely used for cartilage and bone repair, in
modulating both h-MSCs inflammatory and degradative factors
directly involved in the engraftment of specific cell types in a
damaged area. Our data clearly demonstrate that HA in this
3-D conformation acts as a signaling molecule for h-MSCs, so
suggesting a possible role in tissue engineering of osteoarthritis
patients.
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Purpose: Adult mesenchymal stem cells (MSCs) isolated
from bone marrow (BM) are adherent stromal cells of non-
haematopoietic origin with an intrinsic potential to differentiate
into tissues of mesenchymal lineage including bone and carti-
lage. This study concentrates on a comprehensive profiling of
basal gene expression level of osteo-chondro related genes in
undifferentiated versus differentiated rat adult MSCs and on their
cytokine and growth factor profile.
Methods: Immunofluorescence staining and MACS sorting was
used to characterize the MSCs on the basis of their CD profile.
The chondrogenic differentiation potential of these cells was
confirmed by collagen II staining of their extracellular matrix.
Alizarin red positive staining after osteogenic differentiation was
an indicator for osteogenesis. mRNA expression level of selected
genes normalized to β-actin was analyzed by quantitative RT-
PCR. An antibody array was used to demonstrate a differential
cytokine and growth factor profile of the differentiated versus
undifferentiated MSCs.
Results: The MSC population exhibited a CD45-/low, D7fib+ and
CD49a+ cell surface marker profile. Characterization based on
CD71 and CD106 is being carried out by MACS sorting. In
undifferentiated MSCs high gene expression of Sox-9, TGFβ-3
and Cbfa1 was observed whereas Ihh was comparatively low
and BMP-7 was the lowest expressed gene. Chondrogenesis
- stage specific genes COMP, aggrecan, col2a1 and col10a1
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were expressed at low levels, while Col1a1, VEGF and alpha11
integrin were highly expressed together with TIMP-1, TIMP-2
and MMP-13. Upon osteogenic and chondrogenic differentiation
these genes were differentially regulated. Cytokine and growth
factor profile was assessed at protein level using an antibody ar-
ray. Here, we observed secretion of TIMP-1, MCP-1, VEGFα-165,
while CINC-2 and β-NGF were detected intracellulary. This ex-
pression profile was dependent on differentiation state of MSCs
while other factors embedded into the array could not be detected
irrespective of culture conditions.
Conclusions: Our gene expression results provide a founda-
tion for a more reproducible and reliable quality control of rat
bone marrow derived MSCs used for osteo-chondrogenic dif-
ferentiation studies. Additionally, we demonstrate secretion and
production of cytokines and growth factors from a heteroge-
neous BM cell population which may be crucial for MSCs fate
determination and sustenance.
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Purpose: Chondrocytes are essential to maintain the integrity of
the articular cartilage matrix. Freezing of intact articular cartilage,
even in the presence of cryoprotective agents, like glycerol or
dimethyl sulfoxide, seriously compromises the viability of chon-
drocytes and, thus, the integrity and durability of cryopreserved
osteochondral allografts used to repair several types of cartilage
deffects. This study aims at evaluating the ability of the natural
glycosylated hydroquinone, Arbutin, to protect articular chondro-
cytes from the damaging effects of freeze/thawing, using human
tibial plateaus as a model of osteochondral allografts.
Methods: Tibial plateaus were harvested from cadaver tissue
donors within 24 hours of death, in strictly aseptic conditions
according to the standards of the Tissue and Bone Bank of the
University Hospital of Coimbra, Portugal, and the Portuguese
Transplantation Organization. Donor age ranged from 17 to 53
years old. Articular cartilage from all donors appeared grossly
normal without signs of fibrillation or other lesions. The lateral
and medial tibial plateaus from each cadaver tissue donor were
incubated in Ham F-12 Nutrient Mixture with or without arbutin
(50 or 100 mM) for 30 minutes to 1 hour at 37°C and then
frozen at -20°C/24h. After the initial cooling, the osteochondral
pieces were transferred to a biofreezer at -80°C and kept in those
conditions for a maximum of 2 months. Thawing was achieved
by immersion in Ham F-12 Nutrient Mixture at 37°C for 1h.
Chondrocyte viability was assessed in situ by a modification of
the MTT reduction assay and by staining cryostat sections with
Calcein AM and Propidium Iodide. Where applicable, statistical
analysis was performed using the Student’s t test. Results were
considered significant for p<0.05.
Results: Chondrocyte viability in the osteochondral pieces im-
mediately before freezing, was identical in all the conditions
tested. After freeze/thawing, chondrocyte viability, expressed as
the percent MTT reduction relatively to the viability of chondro-
cytes in fresh cartilage, was significantly higher in tibial plateaus
treated with arbutin than in those treated with the nutrient mix-
ture alone (Control), as shown in table 1. However, fluorescence
microscopy showed that living chondrocytes were restricted to
the superficial cartilage layers.
Results are the mean ± SE of 4 different experiments, each
performed in duplicate.
Table 1. Chondrocyte viability in freeze/thawed cartilage relatively to the fresh
tissue
Control Arbutin, Arbutin, Arbutin,
50mM, 30 min 50mM, 1h 100mM, 30 min
11.1 ± 9.4 32.0 ± 10.8 34,2 ± 2.9 28,5 ± 6.2
Conclusions: The results presented indicate that Arbutin is a low
toxicity cryoprotective agent that effectively preserves chondro-
cyte viability, at least, in the superficial cartilage layers. Neverthe-
less, further studies are required to identify conditions of cryop-
reservation with this natural compound that allow the protection
of chondrocytes in the entire depth of the articular cartilage,
which is essential to maintain cartilage integrity in cryopreserved
osteochondral allografts.
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Purpose: Osteoarthritis (OA) as the most prevalent disorder of
the musculoskeletal system is a consequence of mechanical
and biological events destabilizing tissue homeostasis in articu-
lar joint tissues. Thus, it involves the disturbance in the normal
balance of degradation and repair in articular cartilage, synovial
membrane and subchondral bone. Current means and surgical
procedures for an efficient treatment are restricted to symp-
tomatic measures or are quite unsatisfactory in the long-term
evaluation. Tissue Engineering (TE) provides new sustainable
therapy strategies based on the transplantation of cells as sus-
pensions or in combination with scaffolds to the defect side.
Mesenchymal progenitor cells like mesenchymal stem cells and
periosteal progenitor cells meet the demands of regenerating
complex defects like articular knee cartilage and the underlying
bone occurring due OA progression.
Since several years we investigate the regenerative properties
of periosteal progenitor cells. In a new approach we developed
three-dimensional (3D) cell culture techniques comprising the
use of periosteal progenitor cells mixed with fibrinogen and em-
bedded in PGLA biomaterials to allow the formation of osseous
and cartilaginous tissue in vitro and in animal models. The aim of
this study was to characterize human cartilage and bone tissue
engineering on the molecular level.
Methods: With regard to a possible translation into the clinic,
we performed the experiments in a clinically applicable setting:
Human periosteal cells from mastoid (n=3) were isolated and
cultured in complete DME-medium containing human serum.
Passage 3 cells were mixed with human fibrinogen, embed-
ded in PGLA fleeces and induced according to osteogenic or
chondrogenic standard protocols.
Results: After one, two and four weeks of osteogenic induction
the formation of mineralized bone matrix was shown by von
Kossa staining. Chondrogenic differentiation was demonstrated
by collagen type II immunohistochemistry and by alcian blue
staining after two, four and six weeks of induction. Cell viability
was investigated by using PI/FDA staining. RNA from culture
expanded periosteal progenitor cells, 3D bone grafts (timepoint:
7, 14 and 28 days), native bone, 3D cartilage graft (timepoint:
14, 28 and 42 days) and native cartilage were used for genom-
wide gene expression profiling analysis using the Affymetrix HG
U133 plus 2.0 oligonucleotid microarray. The analysis by pat-
tern discovery displayed the regulation of distinct genes already
described as relevant in osteogenesis and chondrogenesis, like
genes involved in matrix formation, and also of possible new
marker genes.
